Article
The CYP19A1 (TTTA)n Repeat Polymorphism May Affect the Prostate Cancer Risk: Evidence from a Meta-Analysis.
American journal of men's health - 1 Jan 2000
Guo Lei, Liu Yanan, Liu Lijun, Shao Shixiu, Cao Yanwei, Guo Jiaming, Niu Haitao
Abstract excerpt
Abnormal aromatase (CYP19A1) expression may participate in prostate cancer (PCa) carcinogenesis. However, the results of studies on the CYP19A1 gene polymorphisms and PCa are conflicting. This meta-analysis aimed to systematically evaluate the associations between the CYP19A1 Arg264Cys polymorphism and the (TTTA)n repeat polymorphism and PCa. Electronic databases (PubMed, EmBase, ScienceDirect, and Cochrane...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
